Controlling mesenchymal stem cell differentiation by TGFβ family members

Journal of Orthopaedic Science

Volumn 8, Issue 5, 2003, Pages 740-748

  Roelen, Bernard A J ^a   Ten Dijke, Peter ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

BMP; Differentiation; Signal transduction; Stem cell; TGF

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; CCAAT ENHANCER BINDING PROTEIN; CHORDIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DNA; DNA BINDING PROTEIN; FOLLISTATIN; FOLLITROPIN; GENE PRODUCT; GROWTH DIFFERENTIATION FACTOR 5; LIGASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYOSTATIN; NOGGIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN SERINE THREONINE KINASE; RECEPTOR; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; COMPLEX FORMATION; CONFERENCE PAPER; GENE; HUMAN; MESENCHYME; MUTATION; NONHUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; SYNOSTOSIS;

EID: 0142026448     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-003-0702-2     Document Type: Article

References (77)

1. Alliston T, Choy L, Ducy P, et al. TGF-β-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 2001;20:2254-72.
2. Asahina I, Sampath TK, Hauschka PV. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 1996;222:38-47.
3. Attisano L, Wrana JL. Signal transduction by the TGF-β superfamily. Science 2002;296:1646-7.
4. Bachiller D, Klingensmith J, Kemp C, et al. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature 2000;403:658-61.
5. Balemans W, Ebeling M, Patel N, et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 2001;10:537-43.
6. Balemans W, van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002;250:231-50.
7. Berk M, Desai SY, Heyman HC, et al. Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development. Genes Dev 1997;11:2029-39.
8. Borton AJ, Frederick JP, Datto MB, The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res 2001;16:1754-64.
9. Boyden LM, Mao, J, Belsky J, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002;346:1513-21.
10. Brunet LJ, McMahon JA, McMahon AP, et al. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 1998;280:1455-7.
11. Brunkow ME, Gardner JC, Van Ness J, et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 2001;68:577-89.
12. Cheifetz S, Bellón T, Calés C, et al. Endoglin is a component of the transforming growth factor-β receptor system in human epithelial cells. J Biol Chem 1992;267:19027-30.
13. Chen D, Ji X, Harris MA, et al. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 1998;142:295-305.
14. Choy L, Skillington J, Derynck R. Roles of autocrine TGF-β receptor and Smad signaling in adipocyte differentiation. J Cell Biol 2000;149:667-80.
15. Choy L, Derynck R. TGF-β inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J Biol Chem 2003;278:9609-19.
16. Cohen A, Mulas R, Seri M, et al. Meier-Gorlin syndrome (ear-patella-short stature syndrome) in an Italian patient: clinical evaluation and analysis of possible candidate genes. Am J Med Genet 2002;107:48-51.
17. -/- mice. Nat Genet 2002;30:106-9.
18. Dickson MC, Martin JS, Cousins FM, et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knockout mice. Development 1995;121:1845-54.
19. Dionne MS, Skarnes WC, Harland RM. Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor beta antagonists. Mol Cell Biol 2001;21:636-43.
20. Gong Y, Krakow D, Marcelino J, et al. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 1999;21:302-4.
21. Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) effects bone accrual and eye development. Cell 2001;107:513-23.
22. Goumans M-J, Mummery C. Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 2000;44:253-65.
23. Grotewold L, Ruther U. The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death. EMBO J 2002;21:966-75.
24. Heldin C-H, Miyazono K, ten Dijke P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:165-71.
25. Jabs EW, Muller U, Li X, et al. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993;75:443-50.
26. Jumlongras D, Bei M, Stimson JM, et al. A nonsense mutation in MSX1 causes Witkop syndrome. Am J Hum Genet 2001;69:67-74.
27. Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 2002;157:303-14.
28. Kingsley DM, Bland AE, Grubber JM, et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGFβ superfamily. Cell 1992;71:399-410.
29. Kingsley DM. The TGF-β superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev 1994;8:133-46.
30. Kinoshita A, Saito T, Tomita H, et al. Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet 2000;26:19-20.
31. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa21 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-64.
32. Lacombe D, Toutain A, Gorlin RJ, et al. Clinical identification of a human equivalent to the short ear (se) murine phenotype. Ann Genet 1994;37:184-91.
33. Langley B, Thomas M, Bishop A, et al. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002;277:49831-40.
34. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001;98:9306-11.
35. Ling N, Ying SY, Ueno N, et al. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986;321:779-82.
36. Little RD, Carulli JP, Del Mastro RG, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002;70:11-9.
37. Liu D, Black BL, Derynck R. TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 2001;150:2950-66.
38. López-Casillas F, Wrana JL, Massagué J. Betaglycan can present ligand to the TGF-β signaling receptor. Cell 1993;73:1435-44.
39. Mao J, Wang J, Liu B, et al. Low-density lipoprotein receptor-related protein-5 binds to axin and regulated the canonical Wnt signaling pathway. Mol Cell 2001;7:801-9.
40. Matzuk MM, Kumar TR, Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 1995;374:356-60.
41. Matzuk MM, Lu N, Vogel H, et al. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995;374:360-3.
42. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 1997;387:83-90.
43. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 1997;94:12457-61.
44. Moustakas A, Souchelnytskyl S, Heldin C-H. Smad regulation in TGF-β signal transduction. J Cell Sci 2001;114:4359-69.
45. Mundlos S, Otto F, Mundlos C, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997;89:773-9.
46. Namiki M, Akiyama S, Katagiri T, et al. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem 1997;272:22046-52.
47. Oh SP, Li E. The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev 1997;11:1812-6.
48. Oike Y, Takakura N, Hata A, et al. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 1999;93:2771-9.
49. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997;89:765-71.
50. Patel MS, Karsenty G. Regulation of bone formation and vision by LRP5. N Engl J Med 2002;346:1572-4.
51. Petrij F, Giles RH, Dauwerse HG, et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995;376:348-51.
52. Polinkovsky A, Robin NH, Thomas JT, et al. Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet 1997;17:18-9.
53. Roberts AB, Anzano MA, Lamb LC, et al. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 1981;78:5339-43.
54. Satokata I, Maas R. Msx-1 deficient mice exhibit cleft palate and abnormalities of cranofacial and tooth development. Nat Genet 1994;6:348-56.
55. Satokata I, Ma L, Ohshima H, et al. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 2000;24:391-5.
56. Sémonin O, Fontaine K, Daviaud C, et al. Identification of three novel mutations of the Noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet 2001;102:314-7.
57. Shi Y. Structural insights on Smad function in TGFβ signaling. Bioessays 2001;23:223-32.
58. Simpson EH, Johnson DK, Hunsicker P, et al. The mouse Cer1 (Cerberus related or homologue) gene is not required for anterior pattern formation. Dev Biol 1999;213:202-6.
59. Storm EE, Huynh TV, Copeland NG, et al. Limb alterations in brachypodism mice due to mutations in a new member of the TGF-β superfamily. Nature 1994;368:639-43.
60. Sun Y, Liu X, Ng-Eaton E, et al. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci USA 1999;96:12442-7.
61. Sutrave P, Kelly AM, Hughes SH. Ski can cause selective growth of skeletal muscle in transgenic mice. Genes Dev 1990;4:1462-72.
62. Thomas JT, Lin K, Nandedkar M, et al. A human chondrodysplasia due to a mutation in a TGF-β superfamily member. Nat Genet 1996;12:315-7.
63. Thomas JT, Kilpatrick MW, Lin K, et al. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 1997;17:58-64.
64. Vale W, River J, Vaughan J, et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986;321:776-9.
65. Vastardis H, Karimbux N, Guthua SW, et al. A human MSX1 homeodomain missense mutation causes selective tooth agenesis. Nat Genet 1996;13:417-21.
66. Wehrli M, Dougan ST, Caldwell K, et al. Arrow encodes an LDL-receptor-related protein essential for wingless signaling. Nature 2000;407:527-30.
67. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000;287:1442-6.
68. Welt C, Sidis Y, Keutmann H, et al. Activins, inhibins, and follistatins: from endocrinology to signaling; a paradigm for the new millennium. Exp Biol Med 2002;227:724-52.
69. Whitman M. Smads and early developmental signaling by the TGF-β superfamily. Genes Dev 1998;12:2445-62.
70. Wilkie AOM, Tang Z, Elanko N, et al. Functional haploin-sufficiency of the human homeobox gene MSX2 causes defects in skull ossification. Nat Genet 2000;24:387-90.
71. Wolfman NM, Hattersley G, Cox K, et al. Ectopic induction of tendon and ligaments in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-β gene family. J Clin Invest 1997;100:321-30.
72. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-34.
73. Wu J-W, Krawitz AR, Chai J, et al. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-β signaling. Cell 2002;111:357-67.
74. Xu MQ, Feldman G, Le Merrer M, et al. Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP). Clin Genet 2000;58:291-8.
75. Yeo C-Y, Whitman M. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol Cell 2001;7:949-57.
76. Yi SE, Daluiski A, Pederson R, et al. The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 2000;127:621-30.
77. Zhang YW, Yasui N, Ito K, et al. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 2000;97:10549-54.